A prospective comparison of intraoperative goal-directed fluid therapy and restrictive fluid therapy on complications in thoracoscopic lobectomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051339

Enrollment

Unknown

Registered

2021-09-20

Start date

2021-09-20

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tumor

Interventions

G group:Target directed fluid therapy

R group:Restrictive fluid therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.The experiment was conducted in Yongchuan Hospital of Chongqing Medical University from October 2020 to May 2021; 2.It can only be carried out after informed consent is signed by the patient and his family.

Exclusion criteria

Exclusion criteria: 1.ASA (American Society of Anesthesiologists) classification greater than III; 2.BMI (body mass index) >28kg/m^2; 3.Serious heart, liver, brain, lung, kidney, metabolic and central nervous system diseases; 4.Patients with skin defects that cannot be measured by NICOM.

Design outcomes

Primary

Measure	Time frame
Intraoperative fluid volume;Use of vasoactive drugs;Postoperative complications;	—

Countries

China

Contacts

Public ContactLi Min

Yongchuan Hospital of Chongqing Medical University

1138268458@qq.com+86 13637857062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026